norovirus
belong
calicivirida
famili
singlestrand
positivesens
rna
virus
genu
noroviru
includ
seven
genogroup
design
gigvii
gi
gii
giv
infect
human
human
norovirus
respons
widespread
outbreak
acut
gastroenter
repres
one
common
caus
foodborn
ill
vaccin
antivir
treatment
option
avail
noroviru
infect
rnadepend
rna
polymeras
rdrp
norovirus
key
enzym
respons
transcript
replic
viral
genom
review
progress
made
understand
structur
function
noroviru
rdrp
use
target
small
molecul
inhibitor
crystal
structur
rdrp
differ
stage
substrat
interact
determin
shed
light
multistep
catalyt
cycl
vitro
assay
vivo
anim
model
develop
identifi
character
inhibitor
noroviru
rdrp
also
summar
follow
updat
current
antivir
research
target
differ
region
noroviru
rdrp
futur
structurebas
drug
design
ration
optim
known
nucleosid
nonnucleosid
inhibitor
noroviru
rdrp
may
pave
way
toward
next
gener
directact
antivir
norovirus
primari
caus
foodborn
ill
global
result
sometim
massiv
outbreak
gastroenter
section
describ
detail
medic
burden
associ
noroviru
current
statu
biomed
effort
address
noroviru
infect
noroviru
genom
organ
human
norovirus
hunov
categori
b
biodefens
agent
major
caus
viral
gastroenter
less
twenti
viral
particl
establish
noroviru
infect
prior
exposur
lead
protect
repeat
infect
clinic
symptom
noroviru
infect
includ
vomit
diarrhea
abdomin
cramp
nausea
usual
last
day
center
diseas
control
prevent
estim
clinic
visit
among
children
result
noroviru
infect
develop
countri
death
annual
children
less
year
age
develop
countri
patel
et
al
scallan
et
al
unit
state
alon
norovirusassoci
foodborn
ill
respons
million
case
yearli
hospit
death
lopman
et
al
healthi
adult
noroviru
caus
acut
selflimit
diseas
last
day
caus
longlast
infect
elderli
juvenil
immunocompromis
patient
norovirus
signific
caus
morbid
mortal
immunocompromis
patient
transplant
recipi
boillat
blanco
et
al
capizzi
et
al
roosweil
et
al
saif
et
al
schorn
et
al
schwartz
et
al
noroviru
infect
infant
lead
seizur
chen
et
al
medici
et
al
link
necrot
enterocol
turciosruiz
et
al
adult
noroviru
infect
exacerb
inflammatori
bowel
diseas
khan
et
al
increas
diseas
sever
link
use
statin
regul
cholesterol
level
rondi
et
al
cultur
cell
treat
statin
increas
noroviru
replic
especi
concern
given
number
patient
use
statin
mann
et
al
despit
clear
need
medic
intervent
prevent
treat
noroviru
infect
approv
vaccin
small
molecul
treatment
option
current
avail
vaccin
small
molecul
current
evalu
potenti
strategi
medic
intervent
case
noroviru
infect
although
vaccin
success
develop
treat
diarrheal
diseas
caus
rna
virus
rotavirus
effort
develop
antinoroviru
vaccin
base
liveattenu
viru
hamper
inabl
grow
hunov
effici
cell
cultur
therefor
current
strategi
develop
antinoroviru
vaccin
reli
product
viruslik
particl
recombin
selfassembl
protein
capsid
recent
review
tan
jiang
richardson
et
al
noroviruslik
particl
produc
varieti
express
system
baculoviru
infect
insect
cell
among
advanc
current
use
manufactur
clinic
trial
materi
oral
nasal
administ
viruslik
particl
well
toler
immunogen
phase
clinic
trial
even
confer
protect
noroviru
gastroenter
healthi
adult
human
experiment
challeng
model
atmar
et
al
elkamari
et
al
tacket
et
al
bival
noroviruslik
particl
candid
safe
immunogen
adult
current
evalu
safeti
children
elderli
efficaci
adult
treanor
et
al
clinic
trial
identifi
date
small
molecul
test
clinic
potenti
antinoroviru
drug
nitazoxanid
origin
develop
commerci
antiprotozo
agent
nitazoxanid
demonstr
benefit
treat
adult
suffer
noroviru
gastroenter
rossignol
elgohari
siddiq
et
al
nitazoxanid
mechan
action
well
understood
probabl
involv
multipl
host
factor
rather
directli
target
noroviru
protein
nitazoxanid
also
inhibit
broad
rang
rna
dna
virus
includ
respiratori
syncyti
viru
parainfluenza
viru
coronaviru
rotaviru
hepat
b
viru
hepat
c
viru
dengu
viru
yellow
fever
viru
japanes
enceph
viru
human
immunodefici
viru
rossignol
antivir
approach
involv
directact
antivir
agent
remain
earli
stage
preclin
research
mainli
target
two
viral
protein
proteas
rna
polymeras
kaufman
et
al
weerasekara
et
al
follow
section
review
focu
structur
function
smallmolecul
inhibit
noroviru
polymeras
norovirus
genet
divers
group
within
calicivirida
famili
includ
six
genera
vesiviru
lagoviru
neboviru
sapoviru
recoviru
noroviru
genu
noroviru
subdivid
seven
genogroup
design
gigvii
base
phylogenet
analysi
capsid
gene
vinj
genogroup
gi
gii
giv
infect
human
caus
acut
gastroenter
noroviru
strain
commonli
isol
case
acut
gastroenter
belong
gi
gii
within
two
group
case
gii
genotyp
infect
account
major
outbreak
gastroenter
norovirus
nonenvelop
virus
positivestrand
genom
nucleotid
genom
typic
contain
three
open
read
frame
orf
name
clark
lambden
mcfadden
et
al
fig
encod
major
minor
structur
capsid
protein
respect
nineti
dimer
form
icosahedr
capsid
noroviru
donaldson
et
al
contain
two
major
domain
shell
domain
protrud
domain
bind
receptor
host
cell
surfac
prasad
et
al
strong
et
al
copi
resid
interior
surfac
capsid
vongpunsawad
et
al
locat
first
twothird
genom
encod
kda
polyprotein
proteolyt
process
virusencod
proteas
yield
nonstructur
protein
name
ntpase
vpg
pro
pol
belliot
et
al
fig
function
nonstructur
protein
list
tabl
involv
viral
replic
complex
format
recruit
host
membran
vesicl
promot
disassembl
golgi
complex
prevent
cell
surfac
protein
express
traffick
facilit
recruit
cellular
membran
replic
complex
ettayebi
hardi
fernandezvega
et
al
contain
endoplasm
reticulum
export
signal
propos
promot
uptak
coat
protein
complex
ii
vesicl
lead
vesic
misloc
golgi
bodi
disassembl
sharp
et
al
sharp
et
al
togeth
interrupt
host
protein
secret
pathway
like
respons
rearrang
cellular
membran
recruit
membran
replic
factori
vpg
coval
link
end
genom
subgenom
rna
linkag
vpg
viral
rna
thought
occur
viral
genom
replic
wherebi
vpg
attach
protein
primer
terminu
genom
rna
rohayem
et
al
proteinprim
initi
rna
synthesi
also
found
picornavirus
potyvirus
goodfellow
noroviru
rdrp
central
enzym
noroviru
rna
replic
viral
rdrp
import
target
antivir
evidenc
efficaci
drug
inhibit
hepat
c
viru
hcv
rdrp
contribut
cure
hcv
infect
therefor
structur
function
studi
noroviru
rdrp
import
understand
noroviru
replic
also
guid
ration
antivir
drug
candid
select
develop
multipl
highresolut
structur
hunov
rdrp
determin
ng
et
al
zamyatkin
et
al
zamyatkin
et
al
zamyatkin
et
al
croci
et
al
b
mastrangelo
et
al
includ
structur
gi
norwalk
viru
hunov
respons
major
human
infect
addit
structur
relat
virus
calicivirida
famili
also
determin
alam
et
al
structur
apoenzym
rdrp
dival
metal
bound
activ
site
rdrp
bound
nucleosid
triphosph
ntp
ternari
complex
templat
rna
primer
sever
ternari
complex
nucleotid
analog
structur
hunov
rdrp
bound
alloster
compound
inhibit
rna
synthesi
also
known
croci
et
al
thu
extens
knowledg
structur
hunov
rdrp
relat
rdrp
function
structur
noroviru
rdrp
highli
similar
positivestrand
rna
virus
alam
et
al
hogbom
et
al
ng
et
al
zamyatkin
et
al
rdrp
describ
partial
close
right
hand
finger
thumb
palm
subdomain
fig
b
finger
thumb
subdomain
interact
close
hand
structur
fig
form
channel
singlestrand
templat
rna
thread
polymeras
templat
channel
merg
central
channel
end
templat
rna
nascent
rna
exit
fig
confluenc
templat
central
chan
nel
ntp
channel
ntp
enter
line
channel
highli
conserv
residu
organ
motif
g
interact
templat
nascent
rna
ntp
rna
synthesi
activ
site
lie
converg
templat
channel
ntp
channel
contain
aspart
residu
coordin
dival
metal
promot
nucleotid
polymer
fig
alam
et
al
zamyatkin
et
al
rna
synthesi
noroviru
rdrp
activ
site
occur
reaction
well
conserv
rdrp
differ
viral
speci
fig
five
step
rdrp
bound
templat
bind
ntp
complementari
templat
base
form
open
ternari
complex
chang
conform
form
close
complex
nucleotidyl
transfer
transloc
templat
conform
chang
complex
releas
pyrophosph
allow
anoth
ntp
bind
activ
site
step
rna
synthesi
involv
signific
conform
chang
rdrp
high
qualiti
structur
captur
sever
distinct
conform
apoenzym
rdrp
ctermin
tail
bound
activ
site
ng
et
al
ternari
complex
norwalk
viru
rdrp
elong
rna
synthesi
determin
zamyatkin
et
al
show
bind
templat
primer
rna
substrat
ntp
displac
ctermin
tail
activ
site
induc
rotat
central
helix
thumb
subdomain
rdrp
form
bind
pocket
primer
rna
zamyatkin
et
al
effect
repres
close
conform
rdrp
trap
prior
nucleotidyl
transfer
activ
site
palm
subdomain
coordin
two
dival
metal
mediat
catalysi
rdrp
fig
metal
form
octahedr
coordin
motif
motif
c
oh
primer
ntp
water
molecul
water
activ
gener
base
extract
proton
primer
oh
enabl
becom
better
nucleophil
metal
b
also
form
octahedr
coordin
carboxyl
group
oxygen
three
phosphat
ntp
side
chain
highli
conserv
motif
f
rdrp
form
electrostat
interact
incom
ntp
like
stabil
pyrophosph
leav
group
ribos
ntp
stabil
van
der
waal
forc
addit
oh
form
hbond
donat
hbond
donat
hbond
fig
network
interact
allow
rdrp
distinguish
ribonucleotid
deoxyribonucleotid
follow
nucleotidyl
transfer
releas
pyrophosph
rdrp
activ
site
remain
close
conform
helic
thumb
subdomain
return
state
similar
seen
apoprotein
zamyatkin
et
al
lead
loosen
contact
rna
duplex
like
facilit
transloc
rna
well
open
pocket
bind
next
nucleotid
accur
initi
rna
synthesi
critic
prevent
loss
viral
genet
inform
kao
et
al
noroviru
rdrp
specif
recogn
viral
genom
rna
synthesi
murin
noroviru
mnv
positiveor
minussens
rna
viral
sgrna
stimul
vpg
nucleotidyl
possibl
stabil
structur
viral
rdrp
goodfellow
mnv
hunov
variant
also
preferenti
recogn
rna
segment
direct
initi
rna
toward
subgenom
rna
subgenom
rna
synthesi
calicivirus
occur
intern
initi
minusstrand
rna
moral
et
al
fig
within
minusstrand
rna
highli
conserv
stemloop
structur
upstream
start
site
sgrna
initi
nucleotid
identifi
calicivirus
fig
mnv
mutat
rna
structur
debilit
mnv
sgrna
synthesi
suppressor
mutat
restor
rna
structur
found
restor
mnv
infect
simmond
et
al
yunu
et
al
mnv
hunov
preferenti
recogn
cognat
subgenom
promot
short
stretch
templat
sequenc
contribut
accur
initi
subgenom
rna
effici
rna
synthesi
crosslink
subgenom
rna
hairpin
mnv
hunov
rdrp
show
helix
thumb
subdomain
mnv
rdrp
contact
mnv
subgenom
promot
hairpin
notabl
mode
recognit
promot
rna
synthesi
similar
phage
rna
polymeras
recogn
promot
sequenc
accur
initi
rna
synthesi
cheetham
et
al
imburgio
et
al
noroviru
initi
rna
synthesi
two
distinct
mode
rohayem
et
al
fig
replic
intermedi
minusstrand
rna
thought
initi
de
novo
mechan
ie
absenc
preexist
primer
case
first
nucleotid
serv
primer
provid
ribos
oh
attach
subsequ
nucleotid
de
novo
initi
allow
rna
synthesi
take
place
opposit
termin
nucleotid
templat
rna
thu
prevent
loss
genet
inform
positivestrand
genom
rna
subgenom
rna
contain
protein
vpg
coval
attach
terminu
protein
unprocess
protein
involv
de
novoiniti
vpgprime
rna
synthesi
belliot
et
al
vpg
essenti
translat
initi
noroviru
genom
subgenom
rna
appear
also
act
recruit
ribosom
daughenbaugh
et
al
thorn
goodfellow
rna
synthesi
noroviru
vpg
contain
tyrosin
like
hunov
whose
hydroxyl
side
chain
involv
rna
synthesi
recent
confirm
mass
spectrometri
olspert
et
al
vitro
purifi
add
uridyl
purifi
vpg
use
vpgpolyu
prime
synthesi
fulllength
subgenom
rna
rohayem
et
al
vpgprime
rna
synthesi
observ
minim
promoterrna
templat
perhap
due
lack
sequenc
cisrepl
element
direct
uridyl
vpg
cisact
replic
element
norovirus
remain
identifi
de
novo
nucleotideiniti
noroviru
subgenom
rna
synthesi
suggest
vpg
could
recogn
way
function
equival
initi
ntp
vpg
also
increas
activ
rdrp
cellbas
report
assay
without
product
vpgprime
rna
suggest
vpg
promot
state
rdrp
compet
rna
synthesi
tion
nucleotidyl
residu
reduc
stimulatori
effect
structur
central
region
mnv
vpg
determin
nuclear
magnet
reson
spectroscopi
support
hypothesi
larg
structur
rearrang
rdrp
requir
recogn
cognat
tyrosin
need
uridyl
leen
et
al
howev
detail
molecular
interact
vpg
unknown
mainli
crystal
structur
protein
complex
yet
avail
activ
noroviru
rdrp
also
modul
noroviru
capsid
protein
enhanc
rna
synthesi
rdrp
concentrationdepend
manner
protein
coexpress
cell
shell
domain
respons
stimulatori
activ
bind
rdrp
subbareddi
et
al
overexpress
mnv
also
stimul
kinet
mnv
replicon
replic
cell
enhanc
rna
synthesi
speci
specif
sinc
mnv
could
enhanc
hunov
rdrp
activ
regulatori
role
activ
viral
structur
protein
viral
rna
synthesi
becom
increasingli
import
theme
rna
virolog
ni
kao
signific
increas
global
incid
noroviru
outbreak
sinc
associ
emerg
highli
transmitt
hunov
lineag
lopman
et
al
siebenga
et
al
pandem
strain
rdrp
display
reduc
replic
fidel
result
higher
mutat
rate
rate
viral
evolut
compar
nonpandem
less
frequent
detect
strain
bull
et
al
winter
season
newli
emerg
isol
outcompet
part
asia
risk
spread
global
lu
et
al
isol
display
evolutionari
rate
least
order
magnitud
higher
seen
establish
role
rdrp
emerg
new
epidem
strain
chan
et
al
hypothesi
rdrpdriven
genet
divers
vital
viral
fit
pathogenesi
uniqu
noroviru
well
document
viru
famili
picornavirus
vignuzzi
et
al
peersen
consist
report
polioviru
polymeras
aria
et
al
report
highfidel
mnv
polymeras
variant
associ
mutat
aria
et
al
mutat
posit
correspond
mnv
clone
display
delay
replic
kinet
vivo
lower
transmiss
rate
compar
wildtyp
viru
impact
singl
point
mutat
rdrp
viral
replic
transmiss
highlight
dynam
interplay
replic
fidel
viral
fit
emerg
domin
strain
noroviru
although
number
small
molecul
antinoroviru
agent
describ
major
remain
earli
stage
preclin
develop
section
review
effort
well
assay
develop
studi
molecul
vitro
assay
vivo
model
avail
character
noroviru
polymeras
inhibitor
product
recombin
noroviru
protein
amen
high
yield
puriti
facilit
develop
noroviru
polymeras
assay
use
inhibitor
test
common
rdrp
assay
base
incorpor
radiolabel
nucleotid
onto
rna
primer
strand
fukushi
et
al
rohayem
et
al
rna
synthesi
initi
de
novo
nonpolyadenyl
negativestrand
rna
contain
specif
promot
sequenc
although
gelbas
assay
provid
qualit
inform
type
rna
form
enzymat
applic
inhibitor
test
optim
adapt
radiometr
readout
format
higher
throughput
purpos
use
fluoresc
readout
base
bind
picogreen
dye
doublestrand
rna
product
even
enhanc
compat
noroviru
rdrp
assay
highthroughput
screen
mastrangelo
et
al
describ
earlier
review
xray
crystallographi
also
valuabl
tool
understand
bind
interact
atom
level
noroviru
rdrp
small
molecul
inhibitor
done
apoprotein
protein
complex
primertempl
ng
et
al
zamyatkin
et
al
final
biophys
method
employ
character
bind
interact
noroviru
polymeras
small
molecul
eg
thermalshift
assay
measur
chang
melt
temperatur
associ
compound
bind
mastrangelo
et
al
fluoresc
polar
assay
measur
proteinrna
bind
recent
attempt
develop
robust
hunov
vitro
replic
assay
fail
lack
permiss
cell
includ
human
macrophag
dendrit
cell
suscept
human
duizer
et
al
herbstkralovetz
et
al
lay
et
al
papafragk
et
al
takanashi
et
al
despit
limit
vitro
effect
small
molecul
hunov
replic
studi
use
stabl
human
hepatoma
cell
line
express
part
norwalk
viru
rna
genom
encod
nonstructur
protein
carri
neomycin
resist
gene
chang
et
al
noroviru
minigenom
replicon
product
viral
rna
lead
reconstitut
function
noroviru
rna
replic
complex
challeng
associ
develop
authent
vitro
infect
assay
hunov
also
led
explor
caliciviru
surrog
amen
cellbas
assay
multipl
nonhuman
enter
caliciviru
system
describ
complet
review
see
rochapereira
et
al
among
mnv
closest
hunov
therefor
broadli
use
inhibit
studi
mnv
replic
well
mous
monocyt
macrophag
wobu
et
al
wobu
et
al
jone
et
al
demonstr
success
infect
human
b
cell
hunov
use
commens
bacteria
cofactor
jone
et
al
jone
et
al
infect
b
cell
result
measur
translat
viral
protein
product
infecti
progeni
increas
viral
genom
copi
signific
overal
low
b
cell
site
hunov
infect
ettayebi
et
al
recent
report
success
cultiv
human
noroviru
stem
cellderiv
human
intestin
enteroid
isol
intestin
crypt
human
intestin
tissu
ettayebi
et
al
addit
bile
enteroid
requir
viru
enhanc
replic
strain
replic
presenc
bile
taken
togeth
like
establish
b
cell
enteroid
vitro
infect
system
find
broad
applic
develop
diagnost
vaccin
therapeut
replic
hunov
describ
use
larg
anim
chimpanze
pig
calv
review
see
rochapereira
et
al
mous
common
speci
vivo
inhibit
studi
small
molecul
immunocompet
mice
infect
mnv
typic
asymptomat
repres
natur
host
mnv
infect
karst
et
al
alon
reactiv
antibodi
found
mous
serum
sampl
research
coloni
across
unit
state
canada
hsu
et
al
strain
noroviru
mnv
mnv
shown
caus
persist
yet
asymptomat
infect
immunocompet
mice
aria
et
al
hsu
et
al
kahan
et
al
shortland
et
al
mnv
infect
immunocompromis
mice
lack
innat
immun
factor
interferon
receptor
result
persist
acut
viru
replic
associ
sever
diarrhea
weight
loss
mortal
karst
et
al
wobu
et
al
particular
knockout
mous
strain
defect
interferon
alphabeta
gamma
receptor
wide
util
model
test
vivo
efficaci
noroviru
polymeras
inhibitor
rochapereira
et
al
particular
strain
mice
also
use
model
dengu
zika
viru
infect
aliota
et
al
johnson
roehrig
zmurko
et
al
smallanim
model
also
develop
studi
hunov
infect
balbc
mice
defici
recombin
activ
gene
rag
common
gamma
chain
permiss
hunov
infect
taub
et
al
replicon
cell
line
express
subgenom
compon
norwalk
viru
enabl
fast
simpl
test
noroviru
replic
inhibitor
ribavirin
one
first
small
molecul
identifi
inhibit
noroviru
vitro
replicon
assay
ribavirin
reduc
viral
genom
protein
weak
halfmaxim
effect
concentr
ec
valu
chang
georg
jin
et
al
fig
combin
interferonalpha
ribavirin
show
addit
effect
inhibit
noroviru
replic
mechan
action
evalu
ad
guanosin
ribavirin
treatment
result
moder
revers
antivir
effect
revers
presenc
guanosin
indic
ribavirin
effect
may
least
partial
associ
deplet
guanosin
triphosph
cell
suggest
mechan
direct
target
polymeras
recent
vitro
work
julian
et
al
use
mnv
suggest
ribavirin
treatment
also
increas
viral
quasispeci
divers
could
contribut
antivir
effect
julian
et
al
nucleosid
precursor
favipiravir
structur
relat
ribavirin
fig
origin
develop
influenza
viru
review
furuta
et
al
molecul
also
shown
inhibit
rna
virus
includ
member
orthomyxo
noro
bunya
arena
flavivirida
furuta
et
al
vitro
antivir
potenc
mnv
replic
fairli
modest
potent
ribavirin
rochapereira
et
al
aria
et
al
jin
et
al
timeofaddit
assay
reveal
exert
activ
timepoint
coincid
onset
viral
rna
synthesi
suggest
might
target
polymeras
noroviru
cell
effici
convert
ribofuranosyl
triphosph
form
rtp
cellular
enzym
furuta
et
al
similar
previou
work
influenza
rtp
recogn
substrat
noroviru
rna
synthesi
result
enzym
inhibit
delay
incomplet
chain
termin
furuta
et
al
jin
et
al
jin
et
al
treatment
norovirusinfect
cell
induc
viral
mutagenesi
vivo
mechan
similar
ribavirin
may
associ
incorpor
nucleotid
analog
viral
rna
aria
et
al
intrins
low
antivir
potenc
prevent
experi
aim
select
drugassoci
resist
mutat
would
otherwis
repres
import
orthogon
valid
propos
mechan
action
attempt
identifi
analog
increas
select
human
polymeras
ad
cmethyl
substitut
limit
success
loss
recognit
human
mitochondri
rna
polymeras
noroviru
rdrp
fig
promis
analog
test
influenza
viru
polymeras
antivir
effect
analog
noroviru
counterpart
report
wang
et
al
nucleosid
analog
cmethylcytidin
origin
develop
polymeras
hcv
advanc
oral
bioavail
valin
ester
prodrug
pierra
et
al
fig
although
valopicitabin
efficaci
chronic
hcvinfect
patient
clinic
develop
halt
advers
event
later
found
inhibit
replic
mnv
rochapereira
et
al
assay
viral
rna
virusinduc
plaqu
format
inhibit
ec
valu
similar
prior
work
timeofaddit
assay
demonstr
act
viral
rna
synthesi
consist
viral
rna
polymeras
antivir
target
target
identif
confirm
biochem
assay
show
triphosph
directli
inhibit
noroviru
polymeras
termin
rna
synthesi
vitro
combin
ribavirin
induc
mark
antagonist
antivir
effect
mechan
clearli
understood
rochapereira
et
al
separ
studi
howev
antagon
observ
ribavirin
costantini
et
al
also
inhibit
hunov
replic
norwalk
viru
replicon
assay
reduc
inhibit
potenc
compar
mnv
assay
rochapereira
et
al
importantli
antivir
activ
hunov
confirm
bcell
line
bjab
infect
assay
ec
valu
significantli
potent
valu
obtain
hunov
replicon
treatment
mnvinfect
mice
prevent
virusinduc
onset
diarrhea
mortal
reduc
viral
load
organ
rochapereira
et
al
even
treatment
start
h
day
postinfect
contrast
reduc
mortal
treatment
initi
onset
symptom
day
postinfect
noroviru
transmiss
model
prophylact
treatment
sentinel
mice
also
protect
transmiss
mnv
infect
rochapereira
et
al
also
antivir
effect
hunov
balbc
mice
nucleosid
analog
cmethylcytidin
cmec
structur
relat
fig
parent
nucleosid
prodrug
mericitabin
hcv
inhibitor
act
chain
termin
reach
phase
clinic
develop
well
toler
cellbas
assay
cmec
compar
antivir
activ
mnv
hunov
costantini
et
al
although
biochem
data
directli
compar
inhibit
effect
target
ntp
result
suggest
cmec
recogn
cytidin
analog
noroviru
polymeras
similar
substrat
effici
reason
would
interest
evalu
antivir
efficaci
cmec
mous
model
noroviru
infect
antivir
activ
first
describ
polioviru
coxsackieviru
demonstr
greater
inhibit
potenc
control
drug
ribavirin
harki
et
al
studi
triphosph
nct
inhibit
polioviru
rdrp
activ
highresolut
structur
noroviru
polymeras
bound
nct
determin
xray
crystallographi
zamyatkin
et
al
structur
rdrp
trap
ternari
complex
includ
selfcomplementari
primertempl
rna
two
metal
ion
mimick
conform
protein
rna
synthesi
nct
molecul
occupi
nucleotid
bind
site
interact
activ
site
residu
hunov
differ
natur
cytidin
triphosph
ie
negativelycharg
nitro
group
nct
posit
close
primer
oh
destabil
transit
state
nucleotidyl
transfer
reaction
fig
nitro
group
also
displac
water
molecul
interact
nct
result
increas
distanc
coordin
metal
final
side
chain
spatial
affect
decreas
interact
nct
like
decreas
effect
stabil
pyrophosph
leav
group
although
aminocytidin
triphosph
act
make
overal
similar
interact
polymeras
noroviru
also
featur
signific
differ
zamyatkin
et
al
nucleobas
act
form
watsoncrick
hydrogen
bond
templat
nucleotid
ribos
exhibit
primarili
pucker
typic
found
rna
fig
ribos
triphosph
act
shift
posit
accommod
amino
group
normal
form
hydrogen
bond
recogn
ribos
oh
place
bind
dival
metal
ion
displac
could
impact
dival
metal
occup
activ
site
result
rel
subtl
chang
primer
oh
act
posit
allow
catalysi
nucleotidyl
transfer
interact
could
import
implic
inhibit
noroviru
rna
replic
nucleotid
analog
although
prior
studi
shown
amino
nucleosid
antivir
effect
virus
unrel
calicivirida
de
clercq
et
al
work
need
demonstr
amino
cytidin
potenti
inhibit
noroviru
replic
suramin
antiparasit
molecul
origin
develop
bayer
long
symmetr
structur
contain
two
charg
naphthalenetrisulfon
acid
head
fig
suramin
also
identifi
vitro
antivir
agent
potent
human
immunodefici
viru
revers
transcriptas
hepat
b
viru
jentsch
et
al
offensperg
et
al
recent
suramin
identifi
silico
dock
search
compound
predict
bind
activ
site
noroviru
polymeras
mastrangelo
et
al
model
exercis
confirm
measur
inhibit
rdrp
activ
hunov
mnv
polymeras
suramin
result
ic
valu
nm
respect
analog
suramin
harbor
two
group
connect
shorter
linker
display
similar
inhibit
potenc
fig
interestingli
also
known
competit
revers
receptor
antagonist
sneddon
et
al
soto
et
al
analysi
detail
bind
mode
suramin
mnv
polymeras
domain
made
possibl
xray
crystallographi
show
molecul
occupi
bind
site
finger
thumb
subdomain
import
interact
two
molecul
tryptophan
demonstr
sitedirect
mutagenesi
result
signific
loss
inhibit
potenc
two
smaller
analog
suramin
naphthalen
disulfon
disulfon
ppnd
retain
level
biochem
effect
also
abl
bind
second
region
protein
locat
thumb
subdomain
croci
et
al
b
tarantino
et
al
fig
one
would
predict
high
inhibit
potenc
suramin
analog
biochem
assay
would
translat
signific
antivir
effect
cell
infect
mnv
howev
suramin
modest
antivir
effect
noroviru
replic
presum
due
low
cell
permeabl
order
advanc
compound
potenti
antinoroviru
drug
attempt
made
improv
cellular
permeabl
deliv
suramin
liposom
separ
studi
show
vitro
vivo
antivir
activ
suramin
enteroviru
member
picornavirida
famili
ren
et
al
studi
report
suramin
block
enteroviru
replic
interf
viral
capsid
assembl
process
taken
togeth
result
indic
suramin
structur
analog
promiscu
binder
interact
multipl
class
protein
includ
limit
noroviru
polymeras
morgan
et
al
torrent
et
al
minim
offtarget
liabil
caus
promiscu
bind
may
possibl
increas
select
class
compound
build
bind
interact
naphthalen
disulfon
ppnd
second
thumb
bind
pocket
noroviru
polymeras
fluorescencebas
picogreen
biochem
assay
use
high
throughput
screen
campaign
identifi
small
molecul
inhibitor
hunov
rdrp
activ
eltahla
et
al
use
model
previous
establish
hcv
polymeras
eltahla
et
al
four
interest
hit
phenylthiazol
carboxamid
pyrazol
acetamid
ic
valu
around
triazol
pyra
zolidinedion
less
potent
polymeras
assay
fig
interestingli
alreadi
report
weakli
inhibit
polioviru
rdrp
campagnola
et
al
three
compound
previous
known
inhibit
viral
polymeras
compound
also
show
consist
cellbas
inhibit
norwalk
replicon
mnv
infect
assay
comparison
significantli
less
potent
inact
replicon
weak
ec
mnv
assay
mode
action
inhibit
studi
suggest
occupi
differ
bind
pocket
hunov
rdrp
howev
find
need
confirm
method
xray
crystallographi
andor
identif
resistanceassoci
mutat
key
role
noroviru
rdrp
play
viral
genom
replic
fact
host
cell
lack
equival
function
make
noroviru
rdrp
attract
target
develop
norovirusspecif
antivir
therapi
although
mani
vitro
vivo
system
avail
identifi
develop
inhibitor
noroviru
rdrp
current
research
field
remain
earli
stage
drug
discoveri
nitazoxanid
small
molecul
evalu
human
clinic
trial
fact
noroviru
typic
caus
short
selflimit
infect
narrow
time
window
therapeut
intervent
limit
effort
interest
develop
antivir
howev
consequ
noroviru
infect
sever
pro
long
vulner
popul
children
elderli
immunocompromis
patient
therefor
increas
commit
develop
small
molecul
treatment
alongsid
current
antinoroviru
vaccin
approach
need
fact
much
alreadi
known
specif
recognit
nucleotid
nucleotid
analog
guid
structurebas
inhibitor
design
addit
locat
hunov
rdrp
bind
nonnucleosid
inhibitor
also
identifi
character
final
sinc
noroviru
rdrp
share
function
structur
featur
protein
rna
virus
hcv
may
possibl
identifi
nucleo
st
ide
analog
like
inhibit
rang
viral
polymeras
identifi
novel
broadspectrum
nucleosid
nonnucleosid
molecul
block
rdrp
inhibit
panel
positivestrand
rna
virus
includ
noroviru
provid
excit
prospect
futur
antivir
therapi
